| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $503.1M | +19.4% |
| Cost of Revenue | $461.6M | +21.5% |
| R&D Expense | $551.8M | +7.9% |
| SG&A Expense | $600.1M | +17.4% |
| Pre-tax Income | $233.3M | +177.5% |
| Income Tax | -$265.3M | — |
| Net Income | $498.7M | +265.8% |
| EPS (Basic) | $0.46 | +227.8% |
| EPS (Diluted) | $0.39 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.54B | -17.7% |
| Total Assets | $36.25B | +20.5% |
| Total Liabilities | $29.73B | +21.2% |
| Stockholders' Equity | $6.53B | +24.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.12B | +84.5% |
| Investing Cash Flow | -$4.82B | -155.1% |
| Financing Cash Flow | $5.03B | -53.8% |
| +208.3% |